Ahmet Tutuncu

Ahmet Tutuncu, a physician-scientist and CEO of AeroRx Therapeutics, shares his insights on innovative nebulized therapies for COPD. He discusses the development of AERO-007, the first nebulized LABA/LAMA duo, and AERO-111, a groundbreaking triple therapy. The conversation highlights the unique challenges of targeting older COPD patients who struggle with inhalers. Ahmet also explores the renewed investor interest in nebulized solutions following major deals in the industry, reflecting on the mission to improve patient outcomes.